Literature DB >> 15018469

Risk of hepatitis C virus transmission following percutaneous exposure in healthcare workers.

G De Carli1, V Puro, G Ippolito.   

Abstract

BACKGROUND: We wanted to determine the incidence of anti-hepatitis C virus (HCV) seroconversion after percutaneous exposure to infectious fluids of an anti-HCV positive source in healthcare workers (HCW) and to investigate related risk factors. PATIENTS AND METHODS: Prospective observation in 55 Italian hospitals of anti-HCV-negative exposed HCW were followed clinically and serologically for at least 6 months.
RESULTS: Of 4,403 exposed HCW, 14 seroconverted (0.31%; 95% CI 0.15-0.48) after an injury with a hollow-bore, blood-filled needle (14/1,876=0.74%; 95% CI 0.41-1.25). Deep injuries increased the seroconversion risk (OR 6.53; 95% CI 2.01-20.80). Exposure to an HIV co-infected source was associated with an higher, though not yet statistically significant, risk (OR 2.76, 95% CI 0.49-10.77). Source's HCV viremia was available in 674 cases, 566 of whom tested positive, including the nine seroconversion cases for whom this information was available.
CONCLUSION: The risk of acquiring HCV after percutaneous exposure seems to be lower than previously reported. Deep injury, injury with a blood-filled needle and HIV co-infection of source seem to be associated with occupational transmission. Needlestick prevention devices could decrease the risk of infection with HCV and other bloodborne pathogens in HCW.

Entities:  

Mesh:

Year:  2003        PMID: 15018469

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  19 in total

Review 1.  Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.

Authors:  Yaron Rotman; T Jake Liang
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

Review 2.  Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.

Authors:  L M Kucirka; H Sarathy; P Govindan; J H Wolf; T A Ellison; L J Hart; R A Montgomery; R L Ros; D L Segev
Journal:  Am J Transplant       Date:  2011-03-14       Impact factor: 8.086

Review 3.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

Review 4.  Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges.

Authors:  Nick Scott; Margaret Hellard; Emma Sue McBryde
Journal:  Virulence       Date:  2015-08-25       Impact factor: 5.882

Review 5.  Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing.

Authors:  Susanna Naggie; David P Holland; Mark S Sulkowski; David L Thomas
Journal:  Clin Infect Dis       Date:  2016-09-28       Impact factor: 9.079

6.  Guidance on the use of increased infectious risk donors for organ transplantation.

Authors: 
Journal:  Transplantation       Date:  2014-08-27       Impact factor: 4.939

7.  Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection.

Authors:  Jens Martin Werner; Theo Heller; Ann Marie Gordon; Arlene Sheets; Averell H Sherker; Ellen Kessler; Kathleen S Bean; M'Lou Stevens; James Schmitt; Barbara Rehermann
Journal:  Hepatology       Date:  2013-09-30       Impact factor: 17.425

Review 8.  Devices for preventing percutaneous exposure injuries caused by needles in healthcare personnel.

Authors:  Viraj K Reddy; Marie-Claude Lavoie; Jos H Verbeek; Manisha Pahwa
Journal:  Cochrane Database Syst Rev       Date:  2017-11-14

Review 9.  High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).

Authors:  Mohsen Malekinejad; Soodabeh Navadeh; Ali Lotfizadeh; Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Alireza Noroozi
Journal:  Int J Infect Dis       Date:  2015-10-13       Impact factor: 3.623

10.  Isolation of hepatitis C virus in norjizac vials.

Authors:  Katayoon Tayeri; Seyed Ramin Radfar; Majid Yaran; Nazila Kassaian; Zary Nokhodian; Behrooz Ataei; Reza Fadaei
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.